Elizabeth Wallace, MD
Dermatology · Aurora, CONPI 1730436031
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 34.5% of the total. Reporting peaked in 2024 at $120 and has fallen 71.8% since, to $34 in 2025. That places this record below the midpoint for dermatology clinicians in CO, where the typical reported total is $1,877.
Across 9 payments — averaging $25.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$80
- AbbVie$46
- Regeneron Healthcare Solutions, Inc.$31
- Novartis$27
- Integra Lifesciences Corporation$23
- Pfizer$15
- plus $10 from 1 others
Across 26 payments — averaging $3733.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kyowa Kirin Pharmaceutical Development, Inc$96K
- Kyowa Kirin, Inc.$1K
What the payments were for
- Food & beverage$13759%
- Education$9541%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 1 | $80 |
| AbbVie | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Novartis | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $23 |
| Pfizer | 1 | $15 |
| Organon | 2 | $10 |
How this compares
$232 in reported general payments places this provider in the 15th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $209,353 |
| Dupixent PenDupilumab | 15 | $55,433 |
| Dupixent SyringeDupilumab | 13 | $48,592 |
| Pimecrolimus | 18 | $4,132 |
| Acitretin | 11 | $2,655 |
| Clobetasol Propionate | 56 | $2,260 |
| Ketoconazole | 59 | $1,183 |
| Calcipotriene | 11 | $1,173 |
| Fluocinonide | 21 | $1,061 |
| Triamcinolone Acetonide | 92 | $953 |
| Metronidazole | 14 | $846 |
| Fluorouracil | 14 | $754 |
| Doxycycline Hyclate | 24 | $693 |
| Mupirocin | 58 | $578 |
| Minoxidil | 30 | $319 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Aurora
- David NorrisAurora$156K
- Dawnielle EndlyAurora$105K
- Torunn SivesindAurora$93K
- Carla Torres-ZegarraAurora$62K
- Cory DunnickAurora$39K
- Theodore AlkousakisAurora$34K
- Emily GorellAurora$27K
- Ryan GambleAurora$10K
- Jennifer RayAurora$9K
- Ryan OlearyAurora$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.